IGM Biosciences Statistics
Total Valuation
IGMS has a market cap or net worth of $919.93 million. The enterprise value is $713.70 million.
Important Dates
The next estimated earnings date is Friday, November 15, 2024, after market close.
| Earnings Date | Nov 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
IGMS has 59.32 million shares outstanding. The number of shares has increased by 34.98% in one year.
| Current Share Class | 33.93M |
| Shares Outstanding | 59.32M |
| Shares Change (YoY) | +34.98% |
| Shares Change (QoQ) | +0.53% |
| Owned by Insiders (%) | 2.49% |
| Owned by Institutions (%) | 19.93% |
| Float | 11.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 555.13 |
| PB Ratio | 7.60 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 245.17 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.06, with a Debt / Equity ratio of 0.32.
| Current Ratio | 7.06 |
| Quick Ratio | 6.83 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -115.71% and return on invested capital (ROIC) is -63.69%.
| Return on Equity (ROE) | -115.71% |
| Return on Assets (ROA) | -35.99% |
| Return on Capital (ROIC) | -63.69% |
| Revenue Per Employee | $12,996 |
| Profits Per Employee | -$983,938 |
| Employee Count | 224 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IGMS has paid $482,000 in taxes.
| Income Tax | 482,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +217.61% in the last 52 weeks. The beta is 0.19, so IGMS's price volatility has been lower than the market average.
| Beta (5Y) | 0.19 |
| 52-Week Price Change | +217.61% |
| 50-Day Moving Average | 14.45 |
| 200-Day Moving Average | 11.04 |
| Relative Strength Index (RSI) | 49.58 |
| Average Volume (20 Days) | 179,964 |
Short Selling Information
The latest short interest is 3.68 million, so 6.21% of the outstanding shares have been sold short.
| Short Interest | 3.68M |
| Short Previous Month | 4.02M |
| Short % of Shares Out | 6.21% |
| Short % of Float | 31.96% |
| Short Ratio (days to cover) | 7.66 |
Income Statement
In the last 12 months, IGMS had revenue of $2.91 million and -$220.40 million in losses. Loss per share was -$3.67.
| Revenue | 2.91M |
| Gross Profit | -190.09M |
| Operating Income | -235.27M |
| Pretax Income | -236.33M |
| Net Income | -220.40M |
| EBITDA | -226.37M |
| EBIT | -235.27M |
| Loss Per Share | -$3.67 |
Full Income StatementBalance Sheet
The company has $256.38 million in cash and $39.37 million in debt, giving a net cash position of $217.01 million or $3.66 per share.
| Cash & Cash Equivalents | 256.38M |
| Total Debt | 39.37M |
| Net Cash | 217.01M |
| Net Cash Per Share | $3.66 |
| Equity (Book Value) | 122.36M |
| Book Value Per Share | 2.07 |
| Working Capital | 228.36M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$167.92 million and capital expenditures -$8.23 million, giving a free cash flow of -$176.15 million.
| Operating Cash Flow | -167.92M |
| Capital Expenditures | -8.23M |
| Free Cash Flow | -176.15M |
| FCF Per Share | -$2.97 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -8,081.96% |
| Pretax Margin | -7,554.79% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -9,243.66% |
Dividends & Yields
IGMS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -34.98% |
| Shareholder Yield | -34.98% |
| Earnings Yield | -23.68% |
| FCF Yield | -18.93% |
Analyst Forecast
The average price target for IGMS is $14.38, which is -7.28% lower than the current price. The consensus rating is "Hold".
| Price Target | $14.38 |
| Price Target Difference | -7.28% |
| Analyst Consensus | Hold |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 178.89% |
| EPS Growth Forecast (5Y) | -10.45% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IGMS has an Altman Z-Score of -3.9 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.9 |
| Piotroski F-Score | 3 |